Physician profile
Brittany Shingleton
NPI 1053905372
$688.61
in general payments reported to CMS, 2019-2025
17 companies · $610 in 2025
The $610 reported for 2025 was more than what 77% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $29.06 · 2022: $50.00 · 2025: $610.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $610.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $609.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $143.62 | 2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $58.86 | 2025 | Caplyta |
| Lundbeck LLC | $53.50 | 2025 | Rexulti |
| Boehringer Ingelheim Pharmaceuticals, INC. | $50.94 | 2025 | Ofev, Jardiance |
| Amgen INC. | $50.00 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $49.63 | 2025 | Austedo Xr |
| Axsome Therapeutics, INC. | $38.29 | 2025 | Auvelity |
| Sumitomo Pharma America, INC. | $37.46 | 2025 | Gemtesa |
| Astrazeneca Pharmaceuticals LP | $35.16 | 2025 | Airsupra, Breztri |
| Lilly USA, LLC | $33.32 | 2025 | Zepbound, Mounjaro |
| Indivior INC. | $29.06 | 2021 | |
| Dexcom, INC. | $23.03 | 2025 | Dexcom G6 Transmitter |
| Vertex Pharmaceuticals Incorporated | $19.49 | 2025 | |
| Medtronic, INC. | $19.13 | 2025 | Maxtack |
| Pfizer INC. | $17.83 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.73 | 2025 | Xifaxan |
| Exact Sciences Corporation | $13.56 | 2025 | The Cologuard Plus Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittany Shingleton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.